India’s IPO market has opened strong this week with Schloss Bangalore and Aegis Vopak Terminals launching their much-awaited public issues. Backed by Brookfield Asset Management, Schloss owns The Leela Hotels brand, while Aegis Vopak is a major energy storage player. Investors are keenly tracking both listings and their GMP & Subscription Status on Day 1.
The Leela Hotels and Aegis IPO: GMP & Subscription Update In this article, we decode the IPO details, share updated subscription status, GMP momentum, key dates, and provide a step-by-step IPO application guide . Whether you’re a retail investor or HNI, this breakdown will help you make an informed decision.
Also Read: Belrise Industries IPO Allotment Out May 26! Check Status, GMP, Listing Date & Profit Estimate
IPO Overview: Key Dates for The Leela Hotels (Schloss Bangalore)and Aegis Vopak Terminals Here’s a quick look at the critical timelines for both IPOs:
IPO Name Open Date Close Date Allotment Date Refunds Begin Listing Date The Leela Hotels IPO May 26, 2025 May 28, 2025 May 31, 2025 June 3, 2025 June 4, 2025 Aegis Vopak Terminals IPO May 26, 2025 May 28, 2025 May 31, 2025 June 3, 2025 June 4, 2025
The Leela Hotels IPO: Luxury Hospitality Meets Capital Markets The Schloss Bangalore Ltd, owner of The Leela Palaces, Hotels and Resorts, has launched a ₹3,500 crore IPO. It includes a ₹2,500 crore fresh issue and a ₹1,000 crore offer-for-sale (OFS) by promoter Project Ballet Bangalore Holdings (DIFC).
Price Band: ₹413 to ₹435 per shareGrey Market Premium (GMP): ₹13 (as of May 26)Estimated Listing Price: ₹448 (2.99% above issue price)
Day 1 Subscription Status (as of 4:45 PM) QIBs: 0.03x
NIIs: 0.03x
Retail Investors: 0.19x
Total: 0.06x
The IPO’s slow start is common on Day 1, but the upward GMP trend suggests investor confidence may pick up in the next two days.
Also Read: The Leela Hotels IPO
Aegis Vopak Terminals IPO: Energy Storage Giant Enters the Fray Aegis Vopak Terminals, a JV between Aegis Logistics and Royal Vopak , has rolled out its IPO at a price band of ₹223-₹235.
GMP Today (May 26): ₹14.5Estimated Listing Price: ₹249.5 (6.17% premium)
Day 1 Subscription Status (as of 4:48 PM) QIBs: 0.39x
NIIs: 0.03x
Retail Investors: 0.19x
Total: 0.26x
With a solid GMP and strong institutional interest, Aegis Vopak looks set for a robust subscription in coming days .
Step-by-Step Guide to Apply for an IPO in India Want to apply for Schloss or Aegis IPO? Follow these simple steps:
1. Choose Your Platform
Use your demat-enabled trading app or netbanking portal (e.g., Zerodha, Upstox, ICICI Direct, SBI YONO).
2. Select the IPO
Find the IPO under the ‘IPO’ section in your platform. Select either Schloss Bangalore or Aegis Vopak.
3. Enter Bid Details
Select investor type: Retail / HNI / QIB
Enter lot size (check minimum lot)
Choose cut-off price for retail to increase allotment chances
4. UPI Mandate Approval
You’ll receive a UPI payment request . Approve it through your UPI app (e.g., PhonePe, Google Pay).
5. Wait for Allotment
Funds remain blocked until allotment. If shares are allotted, they’ll reflect in your demat account on listing day.
*Pro Tip: Always apply on Day 2 or 3 to better gauge demand through subscription trends.
GMP Trends: What Do They Signal? The grey market premium (GMP) is a helpful early indicator of listing expectations. Here’s how the GMPs are shaping up:
🔹 The Leela Hotels (Schloss Bangalore) 🔹 Aegis Vopak Terminals May 25 GMP: ₹17
May 26 GMP: ₹14.5
While GMPs are not official indicators , many investors track them to estimate listing gains and market sentiment.
Final Thoughts: Should You Subscribe? Both IPOs offer strong fundamentals—Leela Hotels has premium hospitality brand value , while Aegis Vopak rides on India’s energy infrastructure boom .
Though Day 1 subscription was tepid, the positive GMP trends and brand reputation of both firms could drive last-minute rush. Retail investors can consider applying after reviewing Day 2 data and risk appetite.
Disclaimer : The views and investment insights provided here are based on publicly available information and do not constitute financial advice. Readers are advised to conduct their own research or consult certified financial experts before making investment decisions.
